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There is an increased demand of patients to use natural products with 
antidiabetic activity and ethnobotonical survey conducted revealed that 
Sida spinosa Linn. root is used in the treatment of diabetes. The present 
investigation aims to examine the hypoglycemic potential of Sida 
spinosa Linn. root in normal rats.  
The root of Sida spinosa Linn. was extracted using ethanol and water 
and tested for acute toxicity according to OECD 423 guidelines. The 
ethanolic (SSE) and aqueous (SSA) extracts at 200 and 400 mg/kg b.w. 
were screened for blood glucose lowering capacity in normal animals 
(18h fasted rat model) and Glibenclamide (GLB) was used as a standard. 
Serum glucose (SG) levels were estimated using a glucose oxidase-
peroxidase reactive strips and a glucometer. The oral glucose tolerance 
test (OGTT) was carried out in normal rats.   
The results of acute toxicity showed that the animals had good 
tolerance to single doses of SSE/SSA in doses as high as 4000mg/kg 
and were non-lethal. In OGT test, the normoglycemic rats treated with 
higher dose SSE, SSA and GLB (10mg/kg) showed 30.36%, 25.24% 
and 33.21% reduction (P<0.001) in SG level respectively over the 
period of 120 min compared to normal control group. In single dose 
one day study, higher dose of SSE, SSA and GLB showed significant 
(p<0.001) reduction in SG levels (22.3%, 18.2% & 28.6% respectively) 
at 3h after oral administration. The ethanolic extract (400 mg/kg) was 
more effective in reducing the SG level in OGTT compared to aqueous 
extract with improved glucose tolerance.  
The root of Sida spinosa Linn. has potent hypoglycemic activity in 
normal rats justifying its use in indigenous system of medicine. 












Diabetes mellitus (DM) is a disorder 
characterized by chronic hyperglycemia and 
impaired carbohydrate, fat and protein 
metabolism associated with absolute or relative 
deficiency in insulin secretion and/or insulin 
action [1]. The common characteristic feature in 
DM is persistent high glucose level in the blood 
[2]. Untreated hyperglycemia can lead to a 
reduced number of glucose transporters, down 
regulation in the number of insulin receptors as 
well as defect of tissue insulin signal 
transduction. Subsequent to these deteriorations, 
there is an absolute increase in hepatic glucose 
output which leads to fasting hyperglycemia [3] 
which itself manifests adverse effects on β-cell 
insulin secretion and insulin resistance [4]. This 
process leads to long-term damage, dysfunction 
and failure of various organs especially the eyes, 
kidneys, nerves, heart, blood vessels etc. and 
creates a huge economic burden related to the 
management of diabetic complications [5].                     
India is one among the top 10 countries in the 
incidence of diabetes.                                    The 
current treatment of DM includes diet, exercise, 
various oral antidiabetic drugs and insulin 
therapy. The oral hypoglycemic agents such as 
biguanides, sulphonylureas and         α-
glucosidase inhibitors have characteristic profile 
of adverse effects which include frequent 
diarrhea, hypoglycemia, hepatotoxicity, lactic 
acidosis, dyslipidemia, hypertension and 
hypercoagulability [6]. There is an increased 
demand of patients to use natural products with 
antidiabetic activity [7]. On the other hand, a 
large number of herbs have been reported to 
possess hypoglycemic/antihyperglycemic 
properties. They are easily available and 
comparatively safe. Based on an ethnobotonical 
approach, the plant Sida spinosa Linn. has been 
traditionally claimed to possess hypoglycemic 
property [8]. However, the scientific evidence to 
confirm this is still lacking, hence we thought it 
worthwhile to systematically investigate the 
effect of ethanolic and aqueous extracts of root of 
Sida spinosa Linn. on normoglycemic rats. 
Materials and methods  
 Chemicals 
Streptozotocin and Glibenclamide were obtained 
from Himedia Laboratories and Aventis Pharma, 
Mumbai, India, respectively. Blood Glucose, total 
cholesterol, HDL cholesterol and triglyceride 
were determined by commercially available kits 
from ERBA diagnostics Mannheim GMBH, 
Germany. All other chemical were of analytical 
grade and used as received. 
Plant material 
Roots of Sida spinosa Linn. were collected from 
surrounding areas of Dharwad, Karnataka, and 
authenticated by Dr. Hebbar, Government P.U. 
College, Dharwad. A herbarium specimen of the 
plant is kept in the Department of 
Pharmacognosy (SETCPD/Ph.cog/herb/12/2010), 
SET’s College of Pharmacy, Dharwad, 
Karnataka, India. The roots were chopped into 
small pieces, dried under shade, coarsely 
powdered and used for extraction.  
Preparation of extracts 
The ethanolic extract (SSE) was prepared by 
Soxhlet extraction method by taking          200 g 
of powdered root and extracting with 800 ml of 
ethanol. Aqueous extract (SSA) was prepared by 
cold maceration method using powdered root 
(100 g) soaked in 1000 ml of distilled water for 7 
days. Both the extracts were filtered, and the 
filtrates were evaporated using a rotary flash 
evaporator under reduced pressure to dryness. 
Further, the suspensions of SSE/SSA were 
prepared by using tragacanth (2%) in distilled 
water and used for the experiment. 
Animals 
Male albino Wistar rats of 150-200g were used 
for the experiment. Animals were kept in the 
animal house of SET’s College of Pharmacy, 




under controlled conditions of temperature 
(23±2ºC), humidity (50±5%) and 12 h light-dark 
cycle. Animals were fed pellet diet (Golden feed, 
New Delhi) and water ad libitum. All the studies 
conducted were approved by the Institutional 
Animal Ethical Committee (IAEC) of SET’s 
College of Pharmacy, Dharwad, India 
(REG.No.112/1999/CPCSEA) according to 
prescribed guidelines of Committee for the 
Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA), 
Government of India.  All the animals were 
acclimatized for seven days before conducting 
the study. 
Acute toxicity study 
The acute oral toxicity study was carried out as 
per the guidelines set by OECD 423 [9]. Animals 
(n=3) were fasted overnight prior to dosing (food 
but not water was withheld). The dose level to be 
used as the starting dose was 5mg/kg b.w. The 
test substance was administered in a single dose 
by gavage using intubation canula. Animals were 
observed individually after dosing at least once 
during the first 30 minutes, periodically during 
the first 24 h, with special attention given during 
the first 4 h, and daily thereafter, for a total of 14 
days.  
Hypoglycemic activity  
Both the extracts SSE and SSA were evaluated 
for the hypoglycemic activity using following 
experimental models. 
Oral Glucose Tolerance Test (OGTT) in 
normal rats 
OGTT was performed in overnight-fasted (18 h) 
normal rats. The rats were given the standard 
drug and test extracts 30 min prior to glucose (2 
g/kg) administration orally. Serum glucose (SG) 
levels were estimated before glucose load (0 
min), at 30 min, 60 min and 120 min afterwards 
using a glucose oxidase-peroxidase reactive strips 
and a glucometer   (SD Check Gold Blood 
Glucose Meter, Standard Diagnostics, 
Korea).[10] 
The experimental rats were divided into six 
groups of five each: Group 1 was the normal 
control and received vehicle (water) (10 ml/kg, 
p.o), group 2 and 3 were treated with SSE (200 
mg/kg, p.o.) and SSE (400 mg/kg, p.o.) 
respectively, group 4 and Group 5 were treated 
with SSA (200 mg/kg, p.o.) and treated SSA (400 
mg/kg, p.o.) respectively, whereas Group 6 
received Glibenclamide (GLB) (10 mg/kg, p.o.).  
 
The results were expressed as integrated area 
under curve for glucose (AUCglucose) calculated 




 = AUC 12
21
glucose  
 Single dose one day study (18h fasted rat 
model) 
The experimental rats were divided into six 
groups of five each and treated as follows: 
 Group 1 was the normal control and received 
vehicle (water) (10 mg/kg, p.o), group 2 and 3 
were treated with SSE (200 mg/kg, p.o.) and SSE 
(400 mg/kg, p.o.) respectively, group 4 and 
Group 5 were treated with SSA (200 mg/kg, p.o.) 
and treated SSA (400 mg/kg, p.o.) respectively, 
whereas Group 6 received Glibenclamide (GLB) 
(10 mg/kg, p.o.).  
Blood glucose levels were estimated before 
administration of extracts and 1, 2 and 3 h 
afterwards.[11] The results were expressed as 
integrated area under curve for glucose 
(AUCglucose) calculated by trapezoid rule as 
mentioned above. 
 Statistical analysis 
The data were analyzed statistically using 
analysis of variance (ANOVA) followed by 
Tukey’s post test. Values are expressed as Mean 
± Standard errors of mean (S.E.M). 
 
  





 Acute oral toxicity studies  
Acute toxicity study revealed that animals 
showed good tolerance (up to 4000 mg/kg b.w) to 
single doses of SSE and SSA extracts. Both 
extracts produced no noticeable effect on general 
behavior or appearance of the animals and all rats 
survived during and after the test period. 
Therefore, two non-lethal doses (200 and 400 
mg/kg b.w) of SSE and SSA extracts were 
selected for screening of hypoglycemic activity in 
rats. 
Oral glucose tolerance in normal rats 
In simple OGT, administration of glucose (2g/kg) 
produced significant change in SG level of 
normal rats. As depicted in Fig.1, SSE (400 
mg/kg), SSA (400 mg/kg) and GLB (10mg/kg) 
treated normoglycemic rats showed 30.36%, 
25.24%  and 33.21%  reduction (P<0.001) in SG 
level respectively over the period of 120 min 
compared to normal control group. In addition, 
estimation of integrated AUCglucose indicated that 
treatment of normoglycemic rats with SSE, SSA 
and GLB significantly improved glucose 
tolerance over the period of 120 min. Evidently, 
treatment of normoglycemic rats with higher dose 
of SSE and SSA showed good tolerance to 





Figure. 1:  SG levels were measured at 0 min, 30 min, 60 min and 120 min after p.o. administration of glucose (2g/kg 











Table. 1. Effect of SSE and SSA on Blood Glucose levels (mg/dL) in Normoglycemic rats. Each value represents Mean  





    0 h 
 
  1 h 
 
   2 h 
 








90.2 ± 1.8 
GLB(10 mg/kg) 
 
91.4±1.5 84.4±0.9b 78.8 ±1.5 c 65.2 ± 1.4c 
SSE(200mg/kg) 
 
96 ±1.2 91.8±1.8 87.2±1.2  82.2 ± 0.4b
SSE(400mg/kg) 
 
93.6±2.0 90 ± 2.1 82 ±1.1b 72.6 ± 1.9c 
SSA(200mg/kg) 
 


















Figure. 2: SG levels were measured at 0 h, 1 h, 2 h and 3 h after single oral administration of SSE, SSA and GLB. Bar 
graph represents the percentage reduction in glycemia with respect to the initial (0 h) level. Each value represents Mean 
 S.E.M., n=5.   aP < 0.05;  b P<0.01;       c P<0.001 compared to normal control. 





Single dose one day study (18h fasted rat 
model) 
Administration of single dose of both SSE and 
SSA in normal rats showed reduction in SG 
levels at different time intervals compared to 
baseline values i.e. at 0 h of the same group. As 
shown in Fig. 2 and Table. 1, oral administration 
of SSE (400 mg/kg) and GLB caused a 
significant (P<0.001) reduction in SG levels 
(22.3% & 28.6%) respectively at 3 h as compared 
to normal control group. 
 
Discussion 
Diabetes mellitus (DM) is a complex and 
multifarious group of disorders characterized by 
hyperglycaemia that has reached epidemic 
proportions in the present century. Several 
synthetic drugs being utilized have side effects 
and thus searching for a new class of compounds 
is essential to overcome these problems. 
Traditional antidiabetic plants might provide new 
oral hypoglycaemic compounds, which can 
counter the high cost and poor availability of the 
current medicines/present day drugs for many 
rural populations in developing countries. The 
present study was carried out to investigate the 
effect of SSE and SSA on the blood glucose 
levels normoglycemic rats.  
Medicinal plants are widely used by the 
populations of developing countries as alternative 
therapy. Many Indian medicinal plants are 
reported to be useful in diabetes.[12]  In India, 
hundreds of plants are used traditionally for the 
management and/or control of diabetes mellitus. 
Unfortunately only a few of such Indian 
medicinal plants have received scientific scrutiny. 
The present work was therefore designed to study 
the hypoglycemic effect of Sida spinosa Linn. 
root in normal rats.  
In the present study, ethanolic extract of Sida 
spinosa Linn. root produced a significant 
decrease in the blood glucose level at a dose level 
of 400 mg/kg. From the results it is assumed that 
the root extract could be responsible for 
stimulation of insulin release and the observed 
restoration of metabolic activities. A number of 
other plants have also been shown to exert 
hypoglycemic activity through stimulation of 
insulin release.[13] Some plants exhibit 
properties similar to the well-known sulfonylurea 
drugs like glibenclamide; they reduce blood 
glucose in normoglycemic animals.[14] 
Glibenclamide is reported to enhance the activity 
of β cells of pancreas resulting in secretion of 
larger amounts of insulin which in turn brings 
down blood glucose level.[15] 
The present data indicates that higher dose of 
SSE and SSA significantly reduced blood glucose 
levels in normal rats. The efficacy of SSE and 
SSA were comparable to standard GLB. This 
effect could be due to increased insulin secretion 
from pancreatic -cells of islets and/or due to 
enhanced transport of blood glucose to the 
peripheral tissue or by other mechanisms such as 
stimulation of glucose uptake by peripheral tissue 
or inhibition of endogenous glucose production.  
Conclusions 
The ethanolic and aqueous extract of Sida 
spinosa Linn. has potent hypoglycemic activity in 
normal rats. The present investigation aims at 
development of potent phytomedicine for 
treatment/management of diabetes mellitus from 
the title plant.  
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S.E.M  Standard Error Mean 
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SSE Sida spinosa Linn. root ethanolic 
extract 
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